Illumina’s board appointed two new members, including Hologic CEO Stephen MacMillan as the non-executive chair, a move that followed a proxy fight that saw shareholders oust the company’s board chair… [+708 chars]Read More
Grails blood test charts path for diagnosing patients suspected of having cancer in large study ASCO23 Endpoints News
